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a  b  s  t  r  a  c  t
Public  health  interventions  have  unique  characteristics  compared  to  health  technologies,  which  present
additional  challenges  for  economic  evaluation  (EE).  High  quality  EEs  that  are  able  to  address  the  particular
methodological  challenges  are  important  for public  health  decision-makers.  In England,  they  are  even
more pertinent  given  the transition  of public  health  responsibilities  in  2013  from  the  National  Health
Service  to local  government  authorities  where  new  agents  are  shaping  policy  decisions.
Addressing  alcohol  misuse  is  a globally  prioritised  public  health  issue.  This article  provides  a system-
atic  review  of EE  and  priority-setting  studies  for interventions  to  prevent  and  reduce  alcohol  misuse
published  internationally  over  the  past  decade  (2006–2016).  This  review  appraises  the EE  and  priority-
setting  evidence  to establish  whether  it is sufﬁcient  to meet  the  informational  needs  of  public  health
decision-makers.
619 studies  were identiﬁed  via  database  searches.  7  additional  studies  were  identiﬁed  via hand  search-
ing  journals,  grey  literature  and  reference  lists.  27  met  inclusion  criteria.  Methods  identiﬁed  included
cost-utility  analysis  (18),  cost-effectiveness  analysis  (6),  cost-beneﬁt  analysis  (CBA)  (1), cost-consequence
analysis  (CCA)  (1) and  return-on-investment  (1).  The  review  identiﬁed  a lack  of consideration  of  method-
ological  challenges  associated  with  evaluating  public  health  interventions  and  limited  use  of methods
such  as  CBA  and  CCA  which  have been  recommended  as  potentially  useful  for EE  in  public  health.  No
studies  using  other  speciﬁc  priority-setting  tools  were  identiﬁed.
© 2017  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
An increasing need for high quality economic evaluations of
public health interventions is recognised and has been documented
by academics and other commentators [1–4]. Characteristics
unique to public health, compared to healthcare technologies,
present additional challenges to the evaluation of public health
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interventions. The reach of public health intervention conse-
quences is much broader than healthcare technologies where
commonly an individual beneﬁciary can be identiﬁed and the out-
come of interest is health maximisation. The time lag between
intervention and effect can also be considerably longer in public
health, compared to a health technology, where the aim is often
to prevent future morbidity; this poses evaluative challenges in
the form of discounting future costs and beneﬁts and modelling
of longer-term effects. Costs incurred and beneﬁts experienced in
the present are generally valued greater than those in the future,
therefore when modelling interventions with long-term costs and
beneﬁts a discount rate should be applied to reﬂect the reduced
value of future costs and beneﬁts to a decision-maker today; the
discount rate applied may  affect the outcome of an economic eval-
uation, therefore must be chosen carefully.
The reported paucity of high quality economic evaluations in
public health may  in part be due to a lack of consensual method-
https://doi.org/10.1016/j.healthpol.2017.10.003
0168-8510/© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ological guidance on the conduct of economic evaluations in this
area [5–7]. The unique challenges for evaluating public health per-
haps make the use of common evaluative methods, for which
guidelines exist for their conduct and reporting [8–10], such as
cost-utility analysis, insufﬁcient for the task. Consequently, alterna-
tive methods for which there is less established guidance in health
care may  need to be used resulting in public health economists
using a heterogeneity of evaluative methods [11]. The lack of guid-
ance may  also be behind the poor quality of many evaluations
that have been published [12] since a lack of consensus over the
methods to use and the costs and consequences to include [13,14]
could contribute to results of varying quality. This lack of method-
ological consensus prevents easy comparison between different
public health interventions by decision-makers and is unhelpful
for researchers conducting such evaluations.
Several reviews have been conducted looking at methods of
economic evaluation in public health [2,3,5]. Edwards et al. [5] con-
ducted a comprehensive review of guidance documents to identify
potential gaps in instruction for public health evaluations, however
this review did not look at how evaluations are actually being con-
ducted in practice. Owen et al. [2] focussed on the cost-effectiveness
of published National Institute of Health and Care Excellence (NICE)
public health guidance which limited the review to consider only
evaluations that have been used by NICE. Weatherly et al. [3] iden-
tiﬁed evaluative challenges via a review of evaluations that have
been conducted on a range of public health interventions. Whilst
this review was comprehensive, it is limited to evaluations pub-
lished between the years 2000–2005 thus will not have captured
evaluations that have been conducted since recent guidance on
public health economics has been released. For example, the major-
ity of the guidance documents identiﬁed by Edwards et al. [5] was
published after 2005.
In the UK, English public health responsibilities were transferred
to local authorities in 2013. The result of this move is that pol-
icy decisions are being shaped and inﬂuenced by new agents, such
as locally elected politicians. How prioritization decisions will be
made, using which approaches, in this new context merits scrutiny
[15]. Alongside this shift in the public health context in England
and to address the lack of methodological guidance, NICE published
updated guidance on the evaluation of public health interventions
[16]. It recommended that the wider societal and environmental
costs and beneﬁts of public health interventions should be consid-
ered via greater use of methods such as cost-beneﬁt analysis (CBA)
and cost-consequence analysis (CCA) (see NICE glossary [17] p.216
for deﬁnitions of CBA and CCA).
This study will build on the evidence provided by existing
reviews and look at economic evaluations of public health inter-
ventions around alcohol prevention, a globally prioritised issue
[18–20]. The review will identify evaluations from 2006 to 2016
to capture evidence that has been published since Weatherly et al.
[3] conducted their study and since recent recommendations for
methods of evaluating public health interventions have been pub-
lished [5]. This review will also look at methods of priority-setting,
such as option appraisal, (social) return-on-investment (ROI/SROI),
programme budgeting and marginal analysis (PBMA) and multi-
criteria decision analysis (MCDA), to help meet the needs of new
public health decision-makers [15,21].
PBMA and MCDA are both systematic processes to aid resource
prioritization decisions which involve assessing the available
options against a set of criteria (see [22,23] for detailed expla-
nations). SROI studies demonstrate the return on an investment
considering a wider remit than standard ROI as the beneﬁts to
society are also included. Public Health England [24] recently rec-
ommended this tool for use by commissioners in drug and alcohol
treatment areas, however it may  also prove beneﬁcial for invest-
ment decisions around non-treatment related alcohol prevention
interventions.
1.1. Aims and objectives
This review aims to identify the methods of evaluation being
used to appraise interventions to prevent excessive alcohol
consumption and establish whether published studies provide suf-
ﬁcient information to meet the requirements of public health
decision-makers. Particular focus will be given to CBA and CCA,
as recommended by NICE, as well as prioritization tools such as
PBMA and MCDA. Speciﬁc elements of evaluation, inspired by the
work of Weatherly et al. [3] and guidance on methods of pub-
lic health appraisal [25], will provide a focus for the literature
search; guidance speciﬁc to the United States has also been pub-
lished [26] although this review will be focusing on the more recent
guidance produced by NICE. Such elements include: measurement
of outcomes, especially long-term outcomes; study perspectives;
apportioning inter-sectoral costs and consequences; and health-
equity considerations.
2. Methods
A systematic literature review was  carried out by one researcher
with assistance from an information specialist and two  other
researchers who  co-screened records and veriﬁed data extraction.
Details of the protocol for this systematic review were regis-
tered on PROSPERO and can be accessed at www.crd.york.ac.uk/
PROSPERO/display record.asp?ID=CRD42016039063.
2.1. Literature search
A literature search (see Table 1 for main search terms) was car-
ried out in the NHS Economic Evaluation Database (NHS EED) and
Scopus for the time period January 2006 − May  2016. NHS EED
is a database of economic evaluations which have been identi-
ﬁed through a systematic search of the literature by the Centre
for Research and Dissemination (CRD) in York. Since methods of
priority-setting are not included in the search strategy used by the
CRD, an additional search was conducted in Scopus, limited to the
health and social sciences sector, to capture additional priority-
setting studies.
The NHS EED database ceased to be updated from 31st December
2014, therefore a further search was  conducted on the databases
searched by CRD (Medline, Embase, psychINFO and Cinahl) using a
strategy based on that used by CRD in order to capture economic
evaluations published between January 2015 and May  2016 (Full
search strategies for each database can be viewed in Appendix A
of the supplementary material). A hand search of relevant health
economics and economics journals was  also conducted alongside
reference and citation searches of included items.
Grey literature, in the form of public health/health economic
conference abstracts, OpenGrey, governmental departments and
voluntary organisations’ websites and dissertation and thesis
abstracts via ProQuest, was also searched for additional records.
2.2. Eligibility criteria
Economic evaluations, deﬁned as the comparative analysis of
alternatives with respect to their associated costs and health
consequences, or a method of priority-setting deﬁned as a system-
atic method of deciding where investments (and disinvestments)
should be made to best meet the needs of communities, were
included for review. Studies were included if they evaluated a pub-
lic health intervention focussed on preventing alcohol misuse or
reducing excessive alcohol consumption. Interventions to prevent
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Table  1
Key search terms used in literature searches.
Search termsa
Economics
Health Economics
exp Economic Evaluation
exp Health Care Cost
exp “costs and cost analysis”
economic$ or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic$
value for money
budget$
(MCDA or PBMA)
“option appraisal”
“multi$ criteria decision analys$"
“program$ budget$ marginal analys$”
(Priority?setting adj2 method$).
“social return on investment”
(SROI or ROI).
“return on investment”
(intoxica$ or beer or wine)
*drinking behaviour
Alcoholic Beverages
*Binge Drinking
Alcohol Drinking
*Alcoholism
“Drink$ behavio$o¨r “binge drink$"
Alcohol$ adj2 (“use disorder$o¨r abuse or beverage$ or addiction$ or consumption or drink$))
a Exact search strategy differed between databases therefore full strategy not represented here.
alcohol misuse may  be targeted at populations at-risk of drinking to
prevent future excessive consumption of alcohol or may  be targeted
at those who drink harmful levels of alcohol. The precise classi-
ﬁcation of “harmful” alcohol consumption can be deﬁned using a
variety of different measures and may  differ internationally; there-
fore no speciﬁc deﬁnition will be provided as inclusion criteria in
order to allow for the inclusion of a range of studies internationally
and in an array of settings. Examples of such preventive interven-
tions are: national policies such as minimum unit pricing of alcohol
or targeted interventions such as brief interventions in schools or
hospitals. Studies were not excluded by country of origin provided
they were published in English.
Evaluations of pharmacotherapies were excluded as these
would fall within Health Technology Assessment (HTA) rather
than public health evaluation, which often uses far more prescrip-
tive methodology, with the dominant method being cost-utility
analysis [27]. Evaluations of treatments for alcohol dependency,
e.g. detoxiﬁcation or rehabilitation, were also excluded as these
would not be considered preventive; treatments which are part of
a preventive regime, such as screening and brief intervention for
non-treatment seeking individuals, were included. Evaluations of
interventions to prevent harm or injury caused as a result of alcohol
consumption, such as trafﬁc accidents resulting from drunk-driving
or risky sexual behaviour, were excluded unless the intervention
speciﬁcally focussed on reducing alcohol consumption as a primary
objective.
2.3. Data extraction
Studies selected for full-text screen were downloaded into an
Endnote X7 literature database and reviewed against the inclusion
criteria. A data extraction form was developed based on items used
by Drummond et al. [28] in their review which considered sim-
ilar data (see Appendix B in the supplementary material for an
example data extraction). We  then added items relevant to this
study speciﬁcally, such as methods of priority-setting adopted. The
form was piloted using the ﬁrst ﬁve studies, reviewed and rele-
vant amendments made. The ﬁnalised data for extraction included:
intervention and comparators, type of study (randomised con-
trolled trial, non-randomised study or modelling study), population
and setting, study length, time-horizon for analysis, perspective,
method of economic evaluation or priority-setting, extrapolation of
data, reported justiﬁcation, strengths and weaknesses of methods
used, outcomes measured, types of costs included, whether pro-
ductivity changes were accounted for and equity considerations.
3. Results
Six hundred and nineteen studies were retrieved from the
database search after deduplication. Initial screening by two
researchers (SH and YO) identiﬁed 45 studies for full text screen-
ing. A further 5 studies were identiﬁed from hand-searching key
journals and grey literature. Twenty-ﬁve studies were selected
for inclusion in the review. A hand-search of references and
citations of the included studies identiﬁed a further two  items
for review. A total of 27 items were included for review
[29–36,39–44,53,54,57,65,68,70,75–81] (Fig. 1).
The included studies were published between years 2006 and
2015, publication frequency was distributed fairly evenly across
the time period. Studies were conducted in the following coun-
tries: USA (n = 8), UK (n = 5), Australia (n = 5), Netherlands (n = 3),
Denmark (n = 2), Estonia (n = 1), Italy (n = 1), Sweden (n = 1) and
multi-national (OECD) (n = 1).
The most common primary method of economic evaluation
used was  cost-utility analysis (CUA) (n = 18) followed by cost-
effectiveness analysis (CEA) (n = 6), CCA (n = 1) and CBA (n = 1). Six
studies conducted multiple evaluations; four conducted a CEA as a
secondary analysis, one a ROI and one a cost-analysis.
One ROI study was identiﬁed. No studies using other priority-
setting methods were identiﬁed (Table 2).
3.1. Interventions
The most commonly evaluated intervention was  screening and
brief intervention (SBI) which was evaluated in 11/27 studies
followed by tax increases on alcohol (n = 7). The remaining inter-
ventions evaluated ranged from targeted interventions such as
family skills training and different screening variations to popu-
lation level interventions such as advertising bans and raising the
legal alcohol drinking age (Fig. 2).
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Table 2
Overview of studies included in the review and key details, numbered.
Study No. Author Year Country of study Title Intervention Comparator Method of analysisa
1 Angus, C. et al. 2014 Italy Cost-effectiveness of a programme of
screening and brief interventions for
alcohol in primary care in Italy
Alcohol screening and brief interventions
(SBI) in primary care. Two screening
options:
No intervention CUA
•  At next general practitioner (GP) visit
• At registration with GP
2  Barbosa, C. et al. 2015 United States The cost-effectiveness of alcohol
screening, brief intervention and
referral to treatment in emergency and
outpatient medical settings
Screening and brief intervention with
feedback, intervention or treatment
(SBIRT) to all individuals presenting for
emergency care but not speciﬁcally
seeking treatment for substance abuse.
SBIRT in outpatient care CUA & CEA
3  Barrett, B. et al. 2006 United Kingdom Cost-effectiveness of screening and
referral to an alcohol health worker in
alcohol misusing patients attending an
A&E department
Opportunistic identiﬁcation of hazardous
drinking and referral to an alcohol health
worker. Adults attending A&E selectively
screened for alcohol misuse
Information only CEA
4 Byrnes,  J.M. et al. 2010 Australia Cost-effectiveness of volumetric
alcohol taxation in Australia
Volumetric alcohol taxation. Three tax
scenarios modelled:
Current tax policy CUA
•  Maintain current deadweight loss of
taxation
•  Maintain existing taxation revenue
•  Equate to existing rate for spirits
5 Cobiac, L. et al. 2009 Australia Cost-effectiveness of interventions to
prevent alcohol-related disease and
injury in Australia
Eight interventions evaluated (incl.
comparator):
Current Practice (i.e.
random breath testing)
CUA
•  Advertising bans
• Licensing controls restricting opening
hours
•  Brief intervention
• Residential treatment
•  Raise minimum drinking age
• Drink driving campaigns
• Volumetric taxation
6 Cowell, A.J. et al. 2012 United States Cost-effectiveness analysis of
motivational interviewing with
feedback to reduce drinking among a
sample of college students
Motivational interviewing, assessment and
feedback. Four intervention conditions
evaluated:
Incremental
comparison of all
interventions
CEA
•  Assessment only (AO)
• Motivational interviewing (MI)
•  Feedback (FB)
• Motivational interviewing and feedback
(MIFB)
7  Crawford, M.J. et al. 2014 United Kingdom The clinical and cost-effectiveness of
brief advice for excessive alcohol
consumption among people attending
sexual health clinics: a randomised
controlled trial
Opportunistic brief advice for excessive
alcohol use among people who attend
sexual health clinics
General health information
leaﬂet provided
CUA
8  Drummond, C. et al. 2009 United Kingdom Effectiveness and cost-effectiveness of
a  stepped care intervention for alcohol
use disorders in primary care: pilot
study
Stepped care alcohol intervention Brief intervention CUA
9  Havard, A. et al. 2012 Australia Randomized Controlled Trial of Mailed
Personalized Feedback for Problem
Drinkers in the Emergency
Department: The Short-Term Impact
Mailed personalised feedback after
screening in the emergency department
No mailed feedback CEA
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10 Holm, A.L. et al. (a) 2014 Denmark Cost-effectiveness of changes in
alcohol taxation in Denmark: a
modelling study
Alcohol taxation. Three tax scenarios
modelled in:
Current level of
taxation
CUA
•  20% increase in tax
•  100% increase in tax
• 10% decrease in tax
11 Holm, A.L. et al. (b) 2014 Denmark Cost-Effectiveness of Preventive
Interventions to Reduce Alcohol
Consumption in Denmark
Six interventions to reduce alcohol
consumption:
Current practice for
each intervention
CUA
•  30% increase in tax
•  Raise minimum drinking age
• Advertising bans
• Limited retail sale hours
• Brief telephone intervention
•  Longer intervention in prevention
centres
12  Ingels, J.B. et al. 2013 United States Cost-effectiveness of the strong African
American families-teen programme:
1-year follow-up
Family skills training to reduce substance
abuse in African American adolescents
Attention control
intervention
CEA
13 Kapoor,  A. et al. 2009 United
States
Cost-effectiveness of screening for
unhealthy alcohol use with%
carbohydrate deﬁcient transferrin:
results from a literature-based decision
analytic computer model
Screening for unhealthy alcohol abuse
using a%CDT test. Four scenarios modelled:
Incremental
comparison of all
interventions
CUA
•  AUDIT questionnaire only
• %CDT test only
• AUDIT questionnaire followed by%CDT
test
•  No screening
14 Lai,  T. et al. 2007 Estonia Costs, health effects and
cost-effectiveness of alcohol and
tobacco control strategies in Estonia
Five different strategies to reduce alcohol
consumption:
No intervention and
incremental
comparison of all inter-
ventions/interventions
in combination
CUA
•  Excise tax
• Reduced access to alcoholic beverage
retail outlets
• Advertising ban
• Roadside breath-testing
• Brief intervention in primary care
15  Mansdotter, A.M. et al. 2007 Sweden A cost-effectiveness analysis of alcohol
prevention targeting licensed premises
A three component intervention:
community mobilisation, a two-day
responsible beverage service training
course for servers, doormen, and
restaurant owners and increased
enforcement of alcohol laws
No direct comparator CCA & CA
16  Miller, T.R. et al. 2007 United States Effectiveness and beneﬁt-cost of
peer-based workplace substance abuse
prevention coupled with random
testing
Peer-based workplace substance abuse
prevention (PeerCare) with random
alcohol testing
PeerCare programme
without alcohol testing
ROI
17  Miller, T.R. & Hendrie, D. 2008 United States Substance Abuse Prevention Dollars
and Cents: A Cost-Beneﬁt Analysis
School based interventions to prevent
substance abuse (alcohol and drugs and
tobacco).
No direct comparator CBA
18 Navarro, H.J. et al. 2011 Australia The potential cost-effectiveness of
general practitioner delivered brief
intervention for alcohol misuse:
evidence from rural Australia
Screening and brief intervention (SBI) for
risky drinking by a general practitioner.
Three levels of SBI increase modelled:
Current practice CEA
•  10% increase
•  20% increase
•  100% increase
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Table 2 (Continued)
Study No. Author Year Country of study Title Intervention Comparator Method of analysisa
19 Neighbors, C.J. et al. 2010 United States Cost-effectiveness of a motivational
intervention for alcohol-involved
youth in a hospital emergency
department
Motivational interviewing amongst youths
admitted to the emergency department of
a trauma ward for drinking-related injuries
Standard care CUA & CEA
20 Purshouse,  R.C. et al. 2013 United
Kingdom
Modelling the cost-effectiveness of
alcohol screening and brief
interventions in primary care in
England
Alcohol screening and brief interventions
(SBI) in primary care. Two screening
options:
Current practice CUA
•  At next general practitioner (GP) visit
• At registration with GP
21 Sassi,  F. et al. 2015 Multi-
national
Health and economic impacts of key
alcohol policy options
Multiple interventions examined: Interventions
compared to each
other intervention and
to other possible uses
of health funds
CUA
•  Brief interventions
• Tax increases
•  Drink-drive regulation enforcement
(breath-testing)
• Opening hours regulation
•  Treatment of dependence
• Advertising regulation
• Minimum price
• Workplace interventions
•  School-based programmes
22 Shanahan, M.  et al. 2006 Australia Modelling the costs and outcomes of
changing rates of screening for alcohol
misuse by GPs in the Australian context
Four strategies to improve screening and BI
rates for Australian GPs:
Current practice CEA
•  Academic detailing
• Interactive continuing medical
education
•  Computerised reminders
•  Target payments
23 Smit,  F. et al. 2011 Netherlands Modelling the cost-effectiveness of
health care systems for alcohol use
disorders: how implementation of
eHealth interventions improves
cost-effectiveness
eHealth interventions augmenting national
health care system. Two strategies
modelled:
Current practice (no
eHealth intervention)
CUA & ROI
•  Adding eHealth systems to conventional
care
• 50% substitution of conventional
face-to-face with eHealth interventions
24  Solberg, L.I. et al. 2008 United States Primary care intervention to reduce
alcohol misuse: ranking its health
impact and cost effectiveness
Screening and brief intervention in
primary care
No screening CUA
25  Tariq, L. et al. 2009 Netherlands Cost-effectiveness of an opportunistic
screening programme and brief
intervention for excessive alcohol use
in  primary care
Screening and brief intervention in
primary care
Current practice (no SBI) CUA & CEA
26 van  den Berg, M.  et al. 2008 Netherlands The cost-effectiveness of increasing
alcohol taxes: a modelling study
Two  alcohol tax increase scenarios: Current practice CUA &
CEA•  Increase tax on beer only (Dutch
scenario)
• Raise taxes to on beer, wine and spirits
(Swedish scenario)
27  Watson, J. et al. 2013 United Kingdom AESOPS: a randomised controlled trial
of  the clinical effectiveness and
cost-effectiveness of opportunistic
screening and stepped care
interventions for older hazardous
alcohol users in primary care
Opportunistic screening and stepped care
intervention in primary care (20 min
behavioural change counselling,
motivational enhancement therapy, local
specialist alcohol services)
Minimal intervention (brief
advice with
practice/research nurse)
CUA
a Interpreted by review authors, study authors’ stated methods sometimes differed from those stated here.
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Records identified throug h 
datab ase searching
(n=77 1)
Records identified throug h 
additiona l sources
(n=5)
Records screened after 
duplicates removed
(n=61 9)
Records exclud ed 
(n=574)
Full-text  articles assess ed 
for eli gibility
(n=50)
Full-text  articles exclud ed
(n=25)
Records identified from 
reference search
(n=2)
Studies included for review
(n=27)
Fig. 1. Prisma ﬂow diagram.
The majority of interventions were targeted at speciﬁc “at-
risk” groups and therefore in settings such as primary care
(n = 13), hospital emergency departments (n = 4), hospital out-
patients departments (n = 1), schools/universities (n = 3), sexual
health clinics (n = 1), the community (n = 5) and the workplace
(n = 2). Seven studies evaluated interventions on a national level
setting (the frequency of study settings is greater than the total
number of included studies due to several studies considering mul-
tiple settings).
3.2. Study designs
Eight randomised, and one non-randomised, controlled trials
were included in the review; two of those [29,30] considered a
beyond-trial analysis longer than trial follow-up. Neighbors et al.
[29] did not specify the time horizon considered but used a deci-
sion analytic model to estimate the number of quality adjusted life
years (QALYs) saved for their CUA implying a time horizon longer
than trial analysis (6 months) was  considered; Mansdotter et al.
[30] used outcomes data from a previous study to extrapolate a
ﬁve year time horizon.
Eighteen modelling studies were identiﬁed; 10 of those under-
took long-term evaluations which were longer than 30 years
allowing for the long-term beneﬁts of public health preventive
interventions to be captured. Data were taken from the epidemio-
logical literature, results from previous trials, longitudinal studies
and meta-analyses to populate models in order to estimate future
costs and outcomes.
Fig. 2. Frequency of intervention types evaluated.
a The frequency of interventions is greater than the total number of included studies due to several studies considering multiple interventions.
*These interventions do not ﬁt our inclusion criteria, however they were included in studies which evaluated a mix  of interventions, the rest of which did ﬁt our inclusion
criteria, therefore have been included in this ﬁgure for reference.
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Table 3
Number of studies by key study characteristics.
Study Characteristics Studies (n) Study numbers (Table 2)
Cost sectors
Healthcare 25 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
Education 3 6, 17, 21
Criminal Justice 6 2, 3, 8, 19, 24, 17
Law  enforcement 4 10, 11, 15, 17
Environment 0
Employment 0
Social care 7 3, 7, 8, 12, 20, 24, 27
Voluntary 2 3, 12
Private 2 15, 16
Out  of pocket 4 5, 12, 14, 24
Government 7 4, 5, 10, 11, 14, 21, 22
Othera 6 2, 8, 17, 19, 20, 24
Setting
Primary care 13 1, 2, 5, 8, 13, 14, 18, 20, 22, 23, 24, 25, 27
Hospital emergency departments 4 2, 3, 9, 19
Hospital outpatients departments 1 2
Community 5 12, 15, 23, 5, 11
National level (e.g. tax policy) 7 4, 5, 10, 11, 14, 26, 21
School/university 3 6, 17, 21
Sexual health clinics 1 7
Workplace 2 16, 21
Discounting
Costs
3%  13 1, 4, 5, 10, 11, 13, 14, 15, 16, 17, 19, 21, 24
3.5%  1 20
4.0% 2 25, 26
Outcomes
3%  10 1, 4, 5, 10, 11, 13, 14, 15, 24, 17
3.5% 1 20
1.5%  2 25, 26
No  discounting applied 11 2, 3, 6, 7, 8, 9, 12, 18, 22, 23, 27
Time  Horizon
<1 year 5 2, 6, 7, 8, 9
1–5  years 7 3, 12, 15, 16, 18, 23, 27
5–10 years 0
10–30 years 2 1, 20
>30 years/Lifetime 10 5, 10, 11, 13, 14, 17, 21, 24, 25, 26
Unspeciﬁed 3 4, 19, 22
Type of study
RCT 7 3, 6, 7, 8, 9, 12, 27
Non-randomised 1 15
Modelling study 18 1, 2, 4, 5, 10, 11, 13, 14, 16, 17, 18, 20, 21, 22, 23, 24, 25, 26
RCT  + modelling 1 19
Model type
Population model 1 14
ALCMOD 1 23
SAPM 2 20, 1
Multistate life table model 4 4, 5, 10, 11
Markov model 1 13
Decision analytic model 4 2, 18, 19, 22
Algebraic model 1 24
Chronic Disease Model 3 21, 25, 26
Statistical model 1 16
Unspeciﬁed 1 17
Stated Perspective
Healthcare (incl. social care for NHS PSS) 11 1, 4, 5, 7, 10, 11, 20, 23, 25, 26, 27
Societal 6 3, 12, 13, 14, 15, 19
Provider 2 6, 9
Societal + Healthcare 1 24
Societal + Provider 1 2
Societal + Government 1 17
Government 1 22
Employer 1 17
Unspeciﬁed 3 8, 18, 21
Productivity costs separately accounted for
Yes 4 2, 3, 15, 17
No  23 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
aOther costs here refer to those related to automobile accidents, expenses related to property damage and insurance administration expenses.
3.3. Inter-sectoral costs and consequences
Ten unique cost sectors were considered (Table 3); all studies
considered healthcare costs in their analyses with the exception
of two  studies [31,32] that did not. The perspective taken for
analysis determines the costs that will be considered since only
costs relevant to that perspective are included (i.e. a study tak-
ing a healthcare perspective will only consider healthcare costs).
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The two studies that did not include healthcare costs conducted
their evaluations according to an educational provider and societal
perspective respectively. Whilst a societal perspective would tradi-
tionally include healthcare, this particular intervention was based
in non-healthcare community and voluntary services; in their lim-
itations, the authors note that healthcare resource utilisation costs
were not included as would be expected in a full societal perspec-
tive.
Twelve studies stated the use of a healthcare perspective for
their economic evaluation (Table 3). Of those twelve, three were
conducted according to a health and personal social services per-
spective, therefore those studies also included costs to the social
care sector. The perspective inferred from the stated costs included
in the studies’ analysis differed from the stated perspective on three
occasions. These three studies [33–35] additionally included costs
to the government for implementing and enforcing the interven-
tions.
Nine studies claimed to follow a societal or other broad perspec-
tive (Table 3). This perspective is recommended for interventions
where beneﬁts and costs fall outside of the healthcare sector as
is often the case for public health interventions. Similarly to the
studies considering a healthcare perspective, there was  discrep-
ancy between the stated and inferred perspectives in some of the
studies claiming to have considered a societal perspective. Two
studies considered a very narrow range of costs. The perspective
used by Mansdotter et al. [30] would be better interpreted as a
payer perspective since only costs related to implementing the
intervention are considered. Likewise, Kapoor et al. [36] consider
only healthcare and out-of-pocket patient costs which is a very nar-
row interpretation of the impacts to society. In addition, ﬁve of the
nine studies claiming to adhere to a societal perspective did not
explicitly consider productivity costs (deﬁned as work productivity
lost from illness) in their analyses, although one of those studies,
Neighbors et al. [29], justiﬁed excluding estimates of productiv-
ity loss separately by stating that these are implicit in the QALY
estimate. This method of accounting for productivity losses is rec-
ommended by a number of organisations such as the US Panel on
cost-effectiveness analysis [9] and NICE [8], however this is not
universally agreed on and those who disagree encourage speciﬁc
measurement of productivity costs [37,38].
The remaining studies conducted their analyses according to
either an education, government, provider or employer perspec-
tive. The stated perspectives in these cases aligned with those
inferred from the costs reported. Three studies [39–41] did not
specify a perspective.
None of the studies included consequences outside of the health
sector such as beneﬁts from increased employment or to the
environment. The only non-health impacts considered were cost-
savings to the criminal justice sector as a result of reducing violence
levels and thus avoiding resultant costs to the judicial system
[30,42].
3.4. Equity
None of the identiﬁed studies speciﬁcally address or discuss
equity in health in their evaluations; however, inferences about
effects on health inequalities may  be made from data reported in
some of the identiﬁed studies. Three studies [36,43,44] included
subgroup analysis in their evaluations which stratiﬁed outcomes
by gender, age and baseline alcohol consumption. Although not
conducted by the authors, the Shefﬁeld Alcohol Policy Model used
by Purshouse et al. [44] allows for analysis by other variables such
as socioeconomic status which could provide relevant data for an
assessment of health inequalities.
4. Discussion
This review has conﬁrmed the general paucity of economic eval-
uation studies in areas of public health that has been documented
previously [1–4]. Whilst this review can only comment on the sta-
tus of evaluations within the arena of alcohol prevention, it would
be reasonable to expect the results to be applicable to other areas
of public health policy since, compared to other policy areas, alco-
hol is not unique in terms of economic evaluation quality. A lack of
economic evaluation evidence is problematic for decision-making
generally since it limits the basis for accurate, evidence-informed
decisions to be made. However, there are a number of issues spe-
ciﬁc to public health decision making that have been highlighted
in this review. Four are reviewed in the following sub-sections.
4.1. Intervention coverage
Firstly, the identiﬁed literature included evaluations of pri-
mary prevention (more upstream) interventions (e.g. tax increases
or advertising bans), which impact at a whole population level,
and secondary/tertiary prevention (more downstream) interven-
tions (e.g. SBI), which target speciﬁc at-risk populations. The
World Health Organisation (WHO) and the Organisation for Eco-
nomic Co-operation and Development (OECD) have both promoted
upstream, preventive interventions to reduce harm from alcohol
(and public health generally) because of a belief in their superior
cost-effectiveness [45,46]. The literature identiﬁed in this review,
however, focussed more on the evaluations of secondary/tertiary
prevention interventions.
The plethora of articles evaluating interventions such as SBI may
in part be due to a general acknowledgement, promoted by organi-
sations such as the WHO  and the OECD and eminent academics such
as Sir Michael Marmot [47], that upstream interventions are gen-
erally cost-effective, thus inciting less perceived need to conduct
such evaluations. These interventions can, however, be politically
problematic to implement. Lobbying from interest groups and pres-
sure to please voters, particularly in areas whose economy relies
heavily on the food and beverages industry, prevents easy passage
of policies such as alcohol tax increases or limitations on access
[48,49]. Given the politically charged context of alcohol policy
decisions, economic evaluation evidence demonstrating the eco-
nomic beneﬁts, in addition to health and other beneﬁts, could prove
instrumental to the implementation of such interventions. Wanless
[50] argues that health and wealth go hand-in-hand − i.e. healthy
communities tend to be more economically productive − there-
fore if economic evaluations are also able to demonstrate positive
productivity gains from upstream alcohol policies, this could pro-
vide a further counter-argument to those lobbyists opposed to such
interventions.
Upstream interventions can also be more challenging to
evaluate methodologically since attributing effects that occur
downstream to an intervention is already often difﬁcult. Exter-
nal factors will likely also affect the outcome of the intervention
making it difﬁcult to disentangle its impact. An absence of suit-
able data to extrapolate the downstream consequences of upstream
interventions may  offer another explanation for fewer economic
evaluation studies of this type. Natural experiment studies can
provide a means of evaluating upstream interventions [51]; for
example, if policy implementation is staggered across different geo-
graphical areas and external factors can be assumed to be similar
across the regions.
4.2. Long-term considerations
Secondly, the time-horizons adopted in some of the studies
were relatively short and may  not capture the impact of preven-
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tive interventions, the nature of which is to prevent uptake of
unhealthy habits in the future. Long-term health risks from over-
consumption of alcohol, such as various chronic diseases [52],
develop over a sustained period. These health risks are unlikely
to be captured in analytic time-horizons shorter than ten years.
Over half of the evaluations identiﬁed had time horizons of under
ten years but the critical issue is whether the inclusion of longer
term effects would have changed the conclusions. Extrapolation of
data for a longer horizon of analysis would have been unlikely to
change the conclusion of the majority of the trial studies however
at least three studies could have been strengthened from longer-
term data. Crawford et al. [53] conclude that their intervention
of study is not cost-effective due to no signiﬁcant differences in
costs or QALYs between control and intervention groups at six
month follow up. Given the focus on sexual health in this study, six
months may  be insufﬁcient time to expect signiﬁcant differences
in QALYs from participants; whereas a longer time horizon could
allow for any positive effects on participants’ drinking to mani-
fest into better sexual health, and therefore a potential increase in
QALYs gained, in the long-run. Cowell et al. [32] evaluated their
intervention using three month follow-up data, citing potential
decline in intervention effectiveness after this point. Extrapola-
tions would have been useful to determine whether the transitory
effect of the intervention still represents value for money. Given
that Cowell et al. [32] collected data up to 12 months post-
intervention, excluding the longer-term data for their evaluation
may  also represent publication bias. A similar argument can be
made for Havard et al. [54] who evaluate cost-efﬁcacy at six weeks
post-intervention. Six month follow-up is cited as underway, and
has subsequently been published [55] but there has been as yet
no re-estimation of cost-effectiveness based on these longer-term
data.
Funding preventive interventions in public health, which mainly
produce beneﬁts that occur in the future, can be politically difﬁcult
due to an emphasis on meeting near-term targets [56]. Economic
evaluations with long-term time-horizons are therefore impor-
tant in order to demonstrate, with some level of certainty, the
value of diverting limited funds now into programmes that, while
not alleviating problems in the immediate term, may  carry the
kudos of achieving deferred beneﬁts to be appreciated by someone
else.
The limited proportion of studies considering the long-term
consequences of interventions is predominantly driven by the
economic evaluations of randomised controlled trials (RCTs). The
majority of identiﬁed studies limited their analysis to a maxi-
mum  of 12 months post intervention and focused on short-term
outcomes which may  in part be due to the cost and impracti-
calities of conducting RCTs with long-term follow up. Several of
the studies identiﬁed in this review comment on the importance
of understanding the long-term effects of the trial interventions
[32,54,57], particularly considering potential diminishing inter-
vention effect over time. Long-term follow-up would be required
to deﬁnitively capture this; however incorporating trial results
into a model alongside estimated data from literature on such
external factors could enable evaluations to reﬂect a longer-term
analysis of the intervention. This would be most useful in uncer-
tain or costly cases, where modern modelling methods [1] could
be employed to assess the potential long-run value of an inter-
vention and aid better informed decision-making. However, it
may  not be necessary to consider long-run effects of all inter-
vention trials, for example if an intervention is shown to be cost
effective in the short-term and has a very low absolute cost;
a more efﬁcient use of resources could be used to fund the
intervention and monitor the outcomes than devote resources to
modelling.
4.3. Incorporating equity
Thirdly, addressing equity in health did not feature in any of the
evaluation studies despite this being a globally recognised area of
need [58]. This could be due to a lack of knowledge and available
guidance around how to include equity considerations in economic
evaluations or due to a lack of data with which to do so. If the latter
were the case however, one would expect this to be highlighted by
the authors in their study limitations, which is not the case in the
studies identiﬁed in this review.
Methods of incorporating equity are still in relative infancy in
the health economics literature, therefore it is unsurprising that
this element is largely missing from the evaluations identiﬁed in
this review. Recent research on methods to incorporate equity con-
siderations into economic evaluations via CEA has been published
[59,60]. Cookson et al. [59] suggest three possible approaches to
including health equity in economic evaluations: equity impact
analysis, equity constraint analysis and equity weighting analysis.
Equity impact analysis disaggregates relevant costs and outcomes
by equity-relevant sub groups producing a dashboard of various
costs and outcomes by sub group to assess who  beneﬁts and who
loses from each policy option. Equity constraint analysis involves an
assessment of trade-offs between the fairness (in equity terms) and
cost-effectiveness of an intervention. In this analysis, equity is con-
sidered a constraint to seeking cost-effectiveness. Equity weighting
analysis attempts to quantify the value of health equity impacts in
order to analyse trade-offs between equity and health [61].
There is no evidence of attempts to address equity in the iden-
tiﬁed literature of this review using any of the three methods
discussed. Having said this, inferences may  be made from data
reported in some of the studies. Some discussion points raised by
authors, whilst not speciﬁcally targeting health equity, could be
inferred as pertinent. For example, in discussing the impracticality
of achieving the “optimal outcome” of their studied intervention,
Navarro et al. [41] touch on some equality-related issues such as
low adherence to the intervention by the most at-risk group of
drinkers (hazardous drinkers) and lack of access to young males
who are a particularly risky group.
The latter two  methods outlined by Cookson et al. [59,61], equity
constraint analysis and equity weighting analysis, may  be challeng-
ing to implement. However, it could be expected that an attempt
at equity impact analysis be included in an evaluation so that
decision-makers may  consider the effects on health equity along-
side efﬁciency.
4.4. Perspective
Finally, over half of the studies identiﬁed conducted their anal-
ysis according to a healthcare perspective. The Washington panel
on cost-effectiveness in health and medicine proposes the use of
the societal perspective in economic evaluations [9,10] and NICE
in the UK [16] recommends either a public sector or local gov-
ernment perspective as most appropriate for evaluations of public
health interventions. NICE’s recommendation stems from acknowl-
edgement that local government has responsibility for more than
just health, therefore this should be reﬂected in any analysis of
interventions funded by local authorities.
There are often time and resource constraints within studies
which prevent a comprehensive collection of all data required to
truly reﬂect a societal perspective [62] and some costs and beneﬁts
may  be difﬁcult to capture, such as productivity costs (discussed
earlier) or beneﬁts to family members or carers who do not directly
beneﬁt from an intervention. However, attempts should be made
to include as many costs and outcomes relevant to society within
the resources available; prioritising those that are likely to have the
greatest impact on the outcome of the evaluation. Where precise
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data cannot be obtained, tools such as sensitivity analysis [63] can
be used to estimate the uncertainty imposed by the missing data.
Restricting the analysis of a public health intervention to
a healthcare perspective may  under-value an intervention if
cost-savings occur in other sectors or equally over-value the inter-
vention if costs are incurred on other sectors as a result of the
intervention. Byford and Raftery [62] argue that the societal per-
spective is the only perspective that is truly able to address the
opportunity costs to societal welfare of the resources used for the
service when the providers of the service have responsibilities
beyond healthcare. Therefore, according to this argument, over half
of the recent evidence available to public health decision-makers
is limited to a perspective that is more restricted than their actual
remit, especially given the current emphasis on addressing the
wider determinants of health. However, there remains a lack of con-
sensus over what constitutes societal welfare and thus, which costs
and beneﬁts should be included and how these should be valued.
Therefore, prescribing to a societal perspective for analysis implic-
itly applies a judgement on what is considered to be included in
the perspective which, it can be argued, is unlikely to be represent
a complete picture of all socially valuable effects [64].
One of the methodological challenges identiﬁed by Weatherly
et al. [3] was incorporating inter-sectoral costs and consequences.
The ﬁndings from this review echo the issues raised by Weatherly
and colleagues and demonstrate that this challenge has not yet been
resolved. Several studies commented on difﬁculties incorporating
certain costs and outcomes. Most limitations were around obtain-
ing accurate costs either in general [42,65] or speciﬁcally around
non-health costs required for a full societal perspective [31,39].
None of the studies were able to appropriately include non-health
outcomes in their analyses. Identifying methods for researchers to:
i) obtain appropriate data on non-health costs and consequences
and ii) incorporate non-health outcomes into analyses may  thus
be important areas of research to pursue in future. The latter point
brings with it additional limitations since the synthesis of costs
and outcomes across sectors requires judgements on the related
opportunity costs, i.e. what beneﬁts are displaced elsewhere by
diverting resources to a certain intervention. Considering the net
effects of an intervention on the healthcare sector equivalent and
directly comparable to wider society assumes that the opportunity
cost of displaced resources is also equivalent amongst the various
sectors. However, a unit of cost or outcome may  differ in value
between sectors depending on the size of the sector’s budget and
the individual sector’s marginal productivity of producing a unit
of outcome [66]. In order to appropriately compare inter-sectoral
costs and consequences requires a value of net health beneﬁts to be
expressed equivalent to the value of net beneﬁts to wider society
[64].
An alternative approach to both adopting a societal perspective
and synthesising potentially inequivalent costs and beneﬁts could
be to adopt a multi-sectoral perspective in which the net effects
on each relevant sector are displayed in a disaggregated approach
[64,66]. Decision-makers can then review the merits of the inter-
vention to each sector and make a judgement based on their own
interpretation of the trade-offs in terms of costs and beneﬁts to
the relevant sectors. The CCA method would be a useful tool to
represent a multi-sectoral perspective since all costs and effects
are displayed in a disaggregated format for easy comparison. These
could easily be displayed according to each sector. Whilst allow-
ing for a comprehensive presentation of costs and effects, CCA
alone has limitations. The disaggregated approach to presenting
results in a CCA does not guide a transparent basis for decisions,
through the use of cost-effectiveness thresholds for example, which
can open-up the decision to scrutiny for possibly ‘cherry-picking’
results.
4.5. Cost-beneﬁt analysis
A further option to incorporate multi-sector costs and beneﬁts
is through the use of CBA [66]. However, despite suggestions for
greater use of CBA and CCA from organisations such as NICE, there
does not appear to have been a marked increase in the number of
either being published since previous reviews [2,3]. This could be
explained by a number of reasons. Firstly, NICE’s public health guid-
ance recommending the use of CBA and CCA was only published in
2012, therefore it may be too early to see its effect ﬁltering into
published work. Secondly, NICE guidance, whilst accessible to any
researcher, is most relevant to UK studies and only 5 (19%) of the
studies are from UK institutions. Other countries have their own
standards for economic evaluation, for instance Angus et al. [43]
used QALYs because that ﬁtted “standard practice for Italian CEA”
[43]. Thirdly, a lack of available data on relevant outcomes or prob-
lems monetising outcomes, for example Cowell et al. [32] stated
that CEA was chosen over CBA due to difﬁculty in monetizing health
outcomes. Finally, the most commonly used study perspective was
healthcare, therefore the adoption of a CEA or CUA approach is con-
sistent with this. Whether considering the healthcare perspective
meant that important costs and beneﬁts were excluded, which may
have altered the studies’ conclusions, is another question.
Therefore, the question that needs to be asked is whether a lack
of CBA in the literature really matters. Utilising more CBA can be
argued for on the grounds of wanting to provide evaluations that
are a true reﬂection of the impact on society, as argued by Byford
and Raftery [62], or to incorporate means to address/evaluate the
wider determinants of health into economic evaluations which are
important to public health decision-makers. The reporting of CBA
results in monetary terms could be helpful when engaging in dis-
cussion with policy-makers who may  be unfamiliar with health
economics terminology; CBA may  be more readily understood and
therefore more likely to be universally accepted than a CUA, for
example.
However, the potential difﬁculties in monetising certain ben-
eﬁts, such as health mentioned earlier, may  complicate efforts to
incorporate CBA more widely in public health evaluations. Also,
many of the evaluations labelled as “cost-beneﬁt analyses” in the
literature were actually cost-analyses or CUAs [67,68] which does
not instil conﬁdence in the execution of high quality CBA. For
example, the only CBA identiﬁed by this review [69] provides
no explanation of how the stated health beneﬁts are monetised,
which raises concern over the reliability of the ﬁgures used and the
methodological quality of the evaluation. If quality of the study is at
stake, a well-executed CUA or CEA that may  not be able to address
all of a decision-maker’s informational needs could be preferable
to a poorly conducted CBA that attempts to meet those needs but
produces an inferior evaluation.
Additionally, the identiﬁed ROI study [70] was  reported as a
cost-beneﬁt analysis; however, the beneﬁts considered were solely
cost-savings and not monetised health, or other, beneﬁts, there-
fore was not considered a true CBA by our deﬁnition [17]. CBA that
either consider only cost-savings or very narrow beneﬁts such as
avoided fatalities (with no consideration of morbidity or quality of
life) have been reported for policies and interventions that would
be relevant to alcohol prevention and general public health in other
sectors, such as transport economics [71,72]. Whilst it is notewor-
thy that CBA is a respected method of economic evaluation in these
sectors, and provides scope for its use within alcohol prevention
public health, decision-makers should be mindful of whether CBA
accurately reﬂect all the relevant costs and beneﬁts associated with
an intervention. There is clearly room for improvement on the oper-
ationalization of CBA within alcohol prevention and public heath
more broadly. Further research into willingness-to-pay or discrete
choice experiment studies to provide relevant data for measuring
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the beneﬁts of public health interventions, would be beneﬁcial.
Until this gap in the evidence base is ﬁlled, perhaps a compromise
of including a CCA, which is able to provide additional data on costs
and consequences relevant to a decision-maker without the strug-
gle of valuing and synthesising them into a single metric, may  offer
a potential solution.
4.6. Priority-setting
The general lack of published priority-setting studies in the alco-
hol prevention literature indicates that these methods are perhaps
not yet widely considered to be useful by academics for this topic
area, or that such methods are used in practice within local gov-
ernment or other agencies but not reported in academic or (easily
accessible) grey literature. A brief search for priority-setting meth-
ods not limited to alcohol prevention did identify a small number
of studies conducted in public health more broadly and a similar
number within the health technology and medical ﬁelds. This ﬁnd-
ing, alongside recent research into priority setting in public health
[15,21,73] provides scope for more incorporation of methods such
as PBMA, MCDA and SROI within the area of alcohol-prevention.
Methods such as PBMA and MCDA offer decision-makers the
advantage of being able to make resource allocation decisions
using a systematic and transparent approach. These approaches
allow for the consideration of multiple criteria, which is particu-
larly pertinent to a public health decision-maker whose interests
likely extend beyond purely population health maximisation. This
is not to say, however, that pure economic evaluation methods can-
not contribute to prioritization decisions. A number of the studies
identiﬁed in this review demonstrated potential prioritization of
interventions based on their economic evaluations. Cobiac et al.
[33], as part of the Australian ACE-prevention project [74], analysed
combinations of interventions to develop an “optimal intervention
mix” which suggests the order in which interventions should be
implemented based on their cost-effectiveness. In this example a
“league table” approach is used, however the ACE-prevention study
team explicitly justify the evaluative rigour in their approach to
priority-setting compared to the standard league table approach.
Lai et al. [75], following guidance from the
WHO-CHOICE methodology for economic evaluation
(http://www.who.int/choice/en/), present their economic eval-
uation of multiple alcohol interventions as a cost-effectiveness
frontier in which an “expansion path” can be drawn to represent
the most efﬁcient combination of interventions, indicating strate-
gies where resources could be prioritised. The authors [75] do
however note the limitations of this approach given the political
and public interests which also inﬂuence policy choices in reality.
The ability to address limitations such as this justiﬁes greater use
of methods such as PBMA and MCDA.
5. Strengths and limitations
This study reports the results of a detailed systematic review
that identiﬁed literature using several databases to minimise the
risk of missing data. The searches were developed with the assis-
tance of an information specialist to ensure rigour in the search
strategies. Grey literature were also examined in order to capture
relevant unpublished work. Whilst attempts were made to iden-
tify relevant grey literature, this review may  not have captured
all of these sources, for example reports perhaps conducted by
non-academic agencies that have not been externally published or
disseminated. The scope of this review was limited to interventions
that directly aim to reduce or prevent the misuse of alcohol and did
not include interventions to prevent harm as a result of consum-
ing alcohol. Areas such as transport economics and sexual health
would likely include economic evaluations relevant to this broader
scope of alcohol-induced harm and would provide a worthwhile
area for exploration in future research.
Whilst the English public health context provided a focal point
for the analysis of this review, the methodological ﬁndings are
relevant to public health economics researchers internationally.
Regardless of the setting, the inherent nature of public health inter-
ventions requires additional consideration for their evaluation,
therefore the methodological challenges discussed here should be
globally applicable.
6. Conclusions
This review echoes the ﬁndings of earlier research on the paucity
of economic evaluations of public health interventions. The lack
of evidence has implications for decision-making in public health,
speciﬁcally due to particular methodological issues such as the
types of interventions evaluated, the lack of consideration of long-
term outcomes, the lack of wider societal perspectives, and lack of
consideration of the impact on health inequity.
This review has also identiﬁed a gap in methods of evaluation
in the published literature with very limited reporting of the use
of CBA, CBA and priority-setting methods such as MCDA, PBMA,
option appraisal or SROI. Given that the literature has suggested
such methods of evaluation may  be useful to public health decision-
makers, these ﬁndings provide scope for future research into how
these may  be improved or adapted to aid uptake in the evaluation
of public health interventions.
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